48 weeks of high dose (10 mg) bulevirtide as monotherapy or with peginterferon alfa-2a in patients with chronic HBV/HDV co-infection

Heiner Wedemeyer, Katrin Schöneweis, Pavel O. Bogomolov, Vladimir Chulanov, Tatyana Stepanova, Morozov Viacheslav, Lena Allweiss, Maura Dandri, Sandra Ciesek, Ulf Dittmer, Walter-Emil Haefeli, A. Alexandrov, Stephan Urban